Literature DB >> 20009049

Aspirin use, colorectal cancer survival, and loss to follow-up.

Anna E Coghill, Polly A Newcomb, John D Potter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20009049     DOI： 10.1001/jama.2009.1824

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Targeted therapies: Using β-blockers to inhibit breast cancer progression.

Authors:  Desmond G Powe; Frank Entschladen
Journal:  Nat Rev Clin Oncol       Date:  2011-08-02       Impact factor: 66.675

2.  Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Authors:  Anna E Coghill; Polly A Newcomb; Peter T Campbell; Andrea N Burnett-Hartman; Scott V Adams; Elizabeth M Poole; John D Potter; Cornelia M Ulrich
Journal:  Gut       Date:  2010-11-04       Impact factor: 23.059

3.  Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.

Authors:  Theodore M Brasky; Christina S Baik; Christopher G Slatore; Mariela Alvarado; Emily White
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609

4.  Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women.

Authors:  A E Coghill; P A Newcomb; V M Chia; Y Zheng; K J Wernli; M N Passarelli; J D Potter
Journal:  Br J Cancer       Date:  2011-02-08       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.